Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells?
- Published in:
- 2013
- By:
- Publication type:
- journal article
Works matching IS 17762596 AND DT 2013 AND VI 8 AND IP 3
Results: 8
1
2
The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trials.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 3, p. 173, doi. 10.1007/s11523-013-0257-x
- By:
- Publication type:
- Article
3
Lung cancer-initiating cells: a novel target for cancer therapy.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 3, p. 159, doi. 10.1007/s11523-012-0247-4
- By:
- Publication type:
- Article
4
Is 1,25-dihydroxyvitamin D receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells?
- Published in:
- Targeted Oncology, 2013, v. 8, n. 3, p. 189, doi. 10.1007/s11523-013-0255-z
- By:
- Publication type:
- Article
5
The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 3, p. 203, doi. 10.1007/s11523-012-0252-7
- By:
- Publication type:
- Article
6
ASCO 2013: from the rediscovery of old recipes to targeted oncology.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
7
Clinical activity of sunitinib in patients with advanced desmoplastic round cell tumor: a case series.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 3, p. 211, doi. 10.1007/s11523-012-0251-8
- By:
- Publication type:
- Article
8
Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 3, p. 183, doi. 10.1007/s11523-013-0266-9
- By:
- Publication type:
- Article